Back to Search
Start Over
Everest Medicines Enters into Collaboration and License Agreement with Kezar Life Sciences to Develop and Commercialize Zetomipzomib in Greater China and other Asian Markets
- Source :
- Plus Company Updates. September 21, 2023
- Publication Year :
- 2023
-
Abstract
- SHANGHAI: Everest Medicines has issued the following news release: Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.766444018